|
⚲
|
| Keyboard |
| Patient Capital Management LLC
✚
|
|
|---|---|
| CRD # | 307336 |
| SEC # | 801-118170 |
| CIK # | 0001854794 |
| AUM | 2,502.5 M (2026-03-27) |
| Employees | 10 (40% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 410-454-3104 |
| Address | One South Street, Suite 2101 Baltimore, MD 21202 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/27/2026) [Brochure] |
|---|
ITEM 5. FEES AND COMPENSATION The Firm charges its private funds a management fee on a quarterly basis in advance, as specified in the applicable offering documents. The management fee generally will not exceed 0.75% (annually) of the assets under management of the relevant fund. In addition, investors in the private funds typically pay a performance-based allocation to the general partner of the fund. Lower management fees may also be available for different classes of interest that agree to longer lock-up periods or that pay different performance-based allocations to the general partner of the fund. When management fees are paid in advance by a fund, no part of the management fee will be refunded in the event an investor in the fund withdraws, whether voluntarily or involuntarily, all or any portion of the fund investment. The Firm will generally charge separate account clients fees that are similar to those charged to its private fund investors. Separate account clients will typically pay advisory fees based on a percentage of assets in their account(s). Fees may be negotiated depending on the particular circumstances of the client, scope of services provided, size of account(s), service levels, reporting and other arrangements, as agreed with specific clients. In those instances, a client may pay more or less than the fees charged to private fund investors, and more or less than similar clients. All management fees and performance-based compensation are calculated pursuant to the governing documents of the relevant fund or investment management agreement of the relevant separate account client. All clients/investors incur third-party brokerage commissions and other transaction costs, as explained in further detail in the Brokerage Practices section below. Additional third-party costs related mainly to custody, audit, administration, legal advice, tax advice and preparation, banking services, and research and consulting may also apply for clients/investors. In all cases, details concerning applicable fees and expenses are set forth in each respective client’s investment management agreement or relevant private placement memorandum. Alternative Fee Arrangements The Firm may, in its discretion, consider and negotiate fee arrangements that are different from those described above. No Compensation from the Sale of Securities Neither the Firm nor any of its personnel accepts compensation for the sale of securities or other investment products. |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/27/2026) [Brochure] |
|---|
ITEM 7. TYPES OF CLIENTS As discussed in the Advisory Business section above, the Firm provides discretionary investment management services to a mutual fund, a private fund, individuals, institutions, and other private clients. The Firm also provides model investment portfolios to other financial firms that may implement these portfolios for their client accounts. The Firm may also offer investment management services to sophisticated investors on a discretionary basis through separately managed accounts. Although the Firm generally seeks minimum account commitments from its investors/clients of US$ 1,000,000, it can waive such minimums in its discretion. Minimums for separate accounts will be negotiated with such clients. |
| CIK | Period |
|---|---|
| 0001854794 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Royalty Pharma PLC | 0.2 | ||
| Citigroup Inc | 0.2 | ||
| Alphabet Inc | 0.2 | ||
| Amazon Com Inc | 0.1 | ||
| Silversun Technologies Inc | 0.1 | ||
| Nvidia Corp | 0.1 | ||
| UnitedHealth Group Inc | 0.1 | ||
| Energy Transfer Equity LP | 0.1 | ||
| Norwegian Cruise Line Holdings Ltd | 0.1 | ||
| Seadrill Ltd | 0.1 | ||
| Facebook Inc | 0.1 | ||
| CVS Caremark Corp | 0.1 | ||
| Coinbase Global Inc | 0.1 | ||
| Adobe Systems Inc | 0.1 | ||
| Crocs Inc | 0.1 | ||
| Biogen IDEC Inc | 0.1 | ||
| Intrexon Corp | 0.1 | ||
| UAL Corp /DE/ | 0.1 | ||
| Illumina Inc | 0.1 | ||
| Noble Corp PLC | 0.1 | ||
| General Motors Co | 0.1 | ||
| Fiserv Inc | 0.1 | ||
| Chime Financial Inc | 0.1 | ||
| UBS Group AG | 0.0 | ||
| iShares Bitcoin Trust | 0.0 | ||
| Springleaf Holdings Inc | 0.0 | ||
| JDcom Inc | 0.0 | ||
| Expedia Inc | 0.0 | ||
| Delta Air Lines Inc | 0.0 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Patient Partners LP | [2021-02-19] | 134.5 M | 207.2 M |
| Filed 2025-07-17 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 2 | 0.1 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 1 | 1.9 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 1 | 0.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 1 | 0.3 |
| (j) Other investment advisers | 2 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 7 | 2.5 |
| By Discretionary | ||
| Discretionary | 6 | 2.5 |
| Non-Discretionary | 1 | 0.0 |
| Total | 7 | 2.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 2.5 | |
| Total | 7 | 2.5 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Patient Partners GP LLC | Promoter | 1 | 1 | |
| Samantha McLemore | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001854794] | |
| SC 13G | [0001854794] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional, Retail |
| Fund Types | Hedge Fund |
| LEI | 98450071DD4R05AC7677 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Osborne Partners Capital Management LLC
✚
|
CA | 2,651.3 M |
|
The Portfolio Strategy Group LLC
✚
|
NY | 2,621.0 M |
|
SSI Investment Management LLC
✚
|
CA | 2,554.9 M |
|
Arcus Capital Partners LLC
✚
|
GA | 2,512.6 M |
|
Seizert Capital Partners LLC
✚
|
MI | 2,484.8 M |
|
Redwood Investment Management LLC
✚
|
AZ | 2,472.6 M |
|
Prodigy Asset Management LLC
✚
|
NE | 2,435.7 M |
|
Swan Global Management LLC
✚
|
PR | 2,388.2 M |
|
Paradigm Capital Management Inc
✚
|
NY | 2,382.0 M |
|
Check Capital Management Inc
✚
|
CA | 2,370.6 M |